Logo image of OPRA

OPERA LTD-ADR (OPRA) Stock Fundamental Analysis

NASDAQ:OPRA - Nasdaq - US68373M1071 - ADR - Currency: USD

16.98  -0.18 (-1.05%)

After market: 16.91 -0.07 (-0.41%)

Fundamental Rating

7

Taking everything into account, OPRA scores 7 out of 10 in our fundamental rating. OPRA was compared to 284 industry peers in the Software industry. OPRA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. OPRA is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make OPRA suitable for value and growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year OPRA was profitable.
In the past year OPRA had a positive cash flow from operations.
OPRA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years OPRA had a positive operating cash flow.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of OPRA (7.65%) is better than 82.04% of its industry peers.
Looking at the Return On Equity, with a value of 8.59%, OPRA is in the better half of the industry, outperforming 74.65% of the companies in the same industry.
OPRA has a Return On Invested Capital of 8.61%. This is amongst the best in the industry. OPRA outperforms 82.39% of its industry peers.
OPRA had an Average Return On Invested Capital over the past 3 years of 6.40%. This is significantly below the industry average of 12.01%.
The last Return On Invested Capital (8.61%) for OPRA is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.65%
ROE 8.59%
ROIC 8.61%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

OPRA has a Profit Margin of 16.72%. This is amongst the best in the industry. OPRA outperforms 82.39% of its industry peers.
OPRA's Profit Margin has declined in the last couple of years.
OPRA has a better Operating Margin (19.12%) than 86.27% of its industry peers.
With a decent Gross Margin value of 72.56%, OPRA is doing good in the industry, outperforming 62.68% of the companies in the same industry.
OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 19.12%
PM (TTM) 16.72%
GM 72.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OPRA is destroying value.
Compared to 1 year ago, OPRA has more shares outstanding
Compared to 5 years ago, OPRA has less shares outstanding
The debt/assets ratio for OPRA has been reduced compared to a year ago.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

OPRA has an Altman-Z score of 9.50. This indicates that OPRA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.50, OPRA belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
OPRA has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
OPRA has a better Debt to FCF ratio (0.12) than 80.99% of its industry peers.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.01, OPRA is doing good in the industry, outperforming 65.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Altman-Z 9.5
ROIC/WACC0.96
WACC8.93%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.29 indicates that OPRA has no problem at all paying its short term obligations.
OPRA's Current ratio of 2.29 is fine compared to the rest of the industry. OPRA outperforms 65.85% of its industry peers.
OPRA has a Quick Ratio of 2.29. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
OPRA's Quick ratio of 2.29 is fine compared to the rest of the industry. OPRA outperforms 66.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.29
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

8

3. Growth

3.1 Past

The earnings per share for OPRA have decreased strongly by -50.51% in the last year.
The Earnings Per Share has been growing by 29.22% on average over the past years. This is a very strong growth
Looking at the last year, OPRA shows a very strong growth in Revenue. The Revenue has grown by 21.52%.
OPRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.22% yearly.
EPS 1Y (TTM)-50.51%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%-80.42%
Revenue 1Y (TTM)21.52%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%29.05%

3.2 Future

Based on estimates for the next years, OPRA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.42% on average per year.
OPRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.03% yearly.
EPS Next Y21.14%
EPS Next 2Y23.39%
EPS Next 3Y22.8%
EPS Next 5Y21.42%
Revenue Next Year21.78%
Revenue Next 2Y18.98%
Revenue Next 3Y18.13%
Revenue Next 5Y15.03%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.51, OPRA is valued on the expensive side.
Based on the Price/Earnings ratio, OPRA is valued cheaply inside the industry as 81.69% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of OPRA to the average of the S&P500 Index (24.21), we can say OPRA is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.45, OPRA is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OPRA indicates a rather cheap valuation: OPRA is cheaper than 84.51% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.44. OPRA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.51
Fwd PE 14.45
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

OPRA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OPRA is cheaper than 88.73% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OPRA is valued cheaply inside the industry as 82.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.62
EV/EBITDA 12.99
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of OPRA may justify a higher PE ratio.
A more expensive valuation may be justified as OPRA's earnings are expected to grow with 22.80% in the coming years.
PEG (NY)0.83
PEG (5Y)0.6
EPS Next 2Y23.39%
EPS Next 3Y22.8%

5

5. Dividend

5.1 Amount

OPRA has a Yearly Dividend Yield of 4.55%, which is a nice return.
OPRA's Dividend Yield is rather good when compared to the industry average which is at 13.67. OPRA pays more dividend than 98.59% of the companies in the same industry.
OPRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.55%

5.2 History

OPRA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

46.35% of the earnings are spent on dividend by OPRA. This is a bit on the high side, but may be sustainable.
DP46.35%
EPS Next 2Y23.39%
EPS Next 3Y22.8%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPERA LTD-ADR

NASDAQ:OPRA (5/9/2025, 8:00:02 PM)

After market: 16.91 -0.07 (-0.41%)

16.98

-0.18 (-1.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)08-20 2025-08-20/bmo
Inst Owners14.92%
Inst Owner Change0.48%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.52B
Analysts83.08
Price Target26.45 (55.77%)
Short Float %6.29%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 4.55%
Yearly Dividend0.43
Dividend Growth(5Y)N/A
DP46.35%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-06 2025-01-06 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-3.68%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-5.28%
Min EPS beat(4)-23.97%
Max EPS beat(4)4.58%
EPS beat(8)5
Avg EPS beat(8)64.58%
EPS beat(12)6
Avg EPS beat(12)-5.72%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.01%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.71%
Revenue beat(4)2
Avg Revenue beat(4)0.72%
Min Revenue beat(4)-0.89%
Max Revenue beat(4)3.71%
Revenue beat(8)5
Avg Revenue beat(8)0.53%
Revenue beat(12)9
Avg Revenue beat(12)1.87%
Revenue beat(16)13
Avg Revenue beat(16)2.33%
PT rev (1m)-0.82%
PT rev (3m)7.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.8%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)8.78%
Revenue NY rev (1m)1.52%
Revenue NY rev (3m)5.46%
Valuation
Industry RankSector Rank
PE 17.51
Fwd PE 14.45
P/S 3.15
P/FCF 18.62
P/OCF 14.48
P/B 1.62
P/tB 3.68
EV/EBITDA 12.99
EPS(TTM)0.97
EY5.71%
EPS(NY)1.18
Fwd EY6.92%
FCF(TTM)0.91
FCFY5.37%
OCF(TTM)1.17
OCFY6.91%
SpS5.4
BVpS10.5
TBVpS4.61
PEG (NY)0.83
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 7.65%
ROE 8.59%
ROCE 9.68%
ROIC 8.61%
ROICexc 9.93%
ROICexgc 27.35%
OM 19.12%
PM (TTM) 16.72%
GM 72.56%
FCFM 16.9%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)7.3%
ROICexc(5y)N/A
ROICexgc(3y)20.62%
ROICexgc(5y)N/A
ROCE(3y)7.2%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Debt/EBITDA 0.05
Cap/Depr 149.81%
Cap/Sales 4.83%
Interest Coverage 174.29
Cash Conversion 97.24%
Profit Quality 101.07%
Current Ratio 2.29
Quick Ratio 2.29
Altman-Z 9.5
F-Score5
WACC8.93%
ROIC/WACC0.96
Cap/Depr(3y)62.94%
Cap/Depr(5y)43.53%
Cap/Sales(3y)2.11%
Cap/Sales(5y)1.89%
Profit Quality(3y)170.05%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.51%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%-80.42%
EPS Next Y21.14%
EPS Next 2Y23.39%
EPS Next 3Y22.8%
EPS Next 5Y21.42%
Revenue 1Y (TTM)21.52%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%29.05%
Revenue Next Year21.78%
Revenue Next 2Y18.98%
Revenue Next 3Y18.13%
Revenue Next 5Y15.03%
EBIT growth 1Y43.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.94%
EBIT Next 3Y29.35%
EBIT Next 5Y21.6%
FCF growth 1Y1.23%
FCF growth 3Y47.38%
FCF growth 5YN/A
OCF growth 1Y26.84%
OCF growth 3Y58.11%
OCF growth 5YN/A